JIC
CLSD

Johnson Investment Counsel’s Clearside Biomedical CLSD Stock Holding History

Johnson Investment Counsel’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,333
Closed -$31K – 594
2020
Q3 		$31K Hold
1,333
– – ﹤0.01% 571
2020
Q2 		$38K Buy
+1,333
New +$39.3K ﹤0.01% 576
2020
Q1 		– Sell
-1,333
Closed -$58K – 548
2019
Q4 		$58K Hold
1,333
– – ﹤0.01% 597
2019
Q3 		$13K Buy
+1,333
New +$19.1K ﹤0.01% 595

Other funds holding CLSD

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Johnson Investment Counsel's CLSD Position: Q4 2020 in Review

Johnson Investment Counsel sold out of Clearside Biomedical (CLSD) in Q4 2020, closing a stake of 1,333 shares — an estimated $31K sold.

Johnson Investment Counsel first reported a position in CLSD in Q3 2019 and held it in 4 quarters. The position peaked at $58K in Q4 2019. 42 funds tracked by Wall St. Rank hold CLSD as of Q4 2020.

  • Johnson Investment Counsel reported no remaining Clearside Biomedical position as of Q4 2020 after selling out during the quarter.
  • Johnson Investment Counsel sold 1,333 Clearside Biomedical shares in Q4 2020, an estimated $31K.
  • Johnson Investment Counsel first reported a position in Clearside Biomedical in Q3 2019 and held it in 4 quarters.
  • Johnson Investment Counsel's Clearside Biomedical position peaked at $58K in Q4 2019.
  • 42 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2020.

Based on Johnson Investment Counsel's 13F filing for Q4 2020, filed 12 Feb 2021.